Vedolizumab for Inflammatory Bowel Disease: Changing the Game, or More of the Same?

United European Gastroenterology Journal - United States
doi 10.1177/2050640614550672
Full Text
Abstract

Available in full text

Date
Authors
Publisher

SAGE Publications

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy